Full video transcriptClick to expand
Auto-generated transcript of @alphaclubsupps's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00But if your tests are 1800, you must have been on a blast old sum.
- 0:03So if you were on TRT, it would be between 600 and 1100.
- 0:07So if you've been on a blast, fine.
- 0:09But you need to bring that down really,
- 0:11because you're probably going to start to get some sides.
- 0:14High blood pressure, raised E2.
- 0:18You can have to have a look at that.
- 0:21So the juicid dose, if you're not splitting your dose two
- 0:25to three times a week, try that as well.
Is a testosterone level of 1800 ng/dL too high for TRT?
Quick answer
A testosterone level of 1800 ng/dL exceeds the upper reference range for most standard assays and is above guideline-recommended trough targets for TRT, which generally fall between 400 and 700 ng/dL for hypogonadism treatment. At supraphysiologic levels, risks include elevated hematocrit, increased blood pressure, and excess aromatization to estradiol, all of which are captured in routine TRT monitoring labs. Patients on TRT who see levels this high should contact their prescribing provider, not adjust doses independently.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Is a testosterone level of 1800 ng/dL too high for TRT?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Is a testosterone level of 1800 ng/dL too high for TRT? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Is a testosterone level of 1800 ng/dL too high for TRT?" from Alpha Club Supplements UK. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: A testosterone level of 1800 ng/dL exceeds the upper reference range for most standard assays and is above guideline-recommended trough targets for TRT, which generally fall between 400 and 700 ng/dL for hypogonadism treatment.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to alistairmurrayb test level at 1800 could be fine." In this clip, the useful excerpt is: "But if your tests are 1800, you must have been on a blast old sum." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
A testosterone level of 1800 ng/dL exceeds the upper reference range for most standard assays and is above guideline-recommended trough targets for TRT, which generally fall between 400 and 700 ng/dL for hypogonadism treatment.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- A testosterone level of 1800 ng/dL exceeds the upper reference range for most standard assays and is above guideline-recommended trough targets for TRT, which generally fall between 400 and 700 ng/dL for hypogonadism treatment. At supraphysiologic levels, risks include elevated hematocrit, increased blood pressure, and excess aromatization to estradiol, all of which are captured in routine TRT monitoring labs. Patients on TRT who see levels this high should contact their prescribing provider, not adjust doses independently.
- 1800 ng/dL exceeds the upper reference limit on standard testosterone assays, which typically cap normal at 916 to 1050 ng/dL depending on the lab and method used.
- The Endocrine Society (Bhasin et al., 2018) recommends targeting mid-normal physiological testosterone ranges for hypogonadism, generally 400 to 700 ng/dL at trough, not 1100 ng/dL.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 1800 ng/dL exceeds the upper reference limit on standard testosterone assays, which typically cap normal at 916 to 1050 ng/dL depending on the lab and method used.
- The Endocrine Society (Bhasin et al., 2018) recommends targeting mid-normal physiological testosterone ranges for hypogonadism, generally 400 to 700 ng/dL at trough, not 1100 ng/dL.
- Supraphysiologic testosterone drives aromatization to estradiol; Ramasamy et al. (2014, Urology) found that elevated E2 in men on TRT correlates with side effects including sexual dysfunction and fluid retention.
- Cardiovascular risk at sustained high testosterone levels is real: Baggish et al. (2017, Circulation: Heart Failure) documented left ventricular dysfunction and structural changes in long-term high-dose androgen users.
- Splitting testosterone injections to two or three times per week is a clinically recognized strategy for reducing peak serum concentrations and smoothing hormone levels, per AUA 2018 testosterone therapy guidelines.
- Any dose adjustment for elevated testosterone should be made with a prescribing physician who can review full labs including hematocrit, estradiol, and blood pressure, not based on social media advice.
- The term 'blast' used in this video refers to high-dose, often off-label testosterone use common in bodybuilding, a context with substantially different risk profiles than prescribed TRT for hypogonadism.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @alphaclubsupps actually say?
The creator is responding to someone whose testosterone levels came back at 1800 ng/dL. His take: that number is too high for legitimate TRT, which he says should sit "between 600 and 1100." He allows that 1800 might be acceptable during a blast, but says the person needs to bring it down because "you're probably going to start to get some sides" including high blood pressure and elevated estradiol (E2). He also recommends splitting injections two to three times per week as a way to smooth out hormone peaks. These are actually reasonable instincts, even if the delivery is rough around the edges. The core logic, that 1800 ng/dL exceeds what most physicians consider a therapeutic target range, is defensible. But some of the framing is loose enough to cause confusion, particularly around what "blast" means for a viewer who may not know the difference between performance-enhancing use and medical therapy.
Does the science back this up?
Mostly, yes. The American Urological Association and the Endocrine Society both define TRT target ranges that generally fall between 400 and 700 ng/dL as a trough, with some clinicians accepting mid-normal ranges up to around 900 to 1000 ng/dL depending on symptom response. A level of 1800 ng/dL is above the upper limit of most laboratory reference ranges, which typically cap normal at 916 to 1050 ng/dL depending on the assay used.
The cardiovascular concern he raises is not unfounded. Ory et al. (2022, Journal of Clinical Endocrinology and Metabolism) found associations between supraphysiologic testosterone and increased hematocrit and blood pressure. The estradiol point is also grounded in pharmacology: excess testosterone aromatizes into estradiol, and elevated E2 is associated with fluid retention, gynecomastia, and mood changes. Ramasamy et al. (2014, Urology) noted that high E2 in men on TRT correlates with sexual dysfunction and other side effects. The injection frequency advice also has support. Testosterone cypionate and enanthate have multi-day half-lives, and splitting doses reduces peak-to-trough swings, which can reduce side effect burden. This has been discussed in clinical guidance from the American Urological Association (2018 guidelines).
What did they get wrong (or right)?
He got more right than wrong, which is worth saying plainly. The 1800 ng/dL figure being outside a therapeutic target range is accurate. The cardiovascular and E2 concerns are real. The injection splitting advice is clinically reasonable and often underdiscussed.
What he got wrong, or at least imprecise: his stated TRT range of "600 to 1100" is on the higher end of what most endocrinologists would target. Many guidelines aim for mid-normal physiological levels, closer to 400 to 700 ng/dL at trough. Framing 1100 as a routine TRT ceiling could give viewers the impression that near-supraphysiologic levels are standard medical practice, which they are not for most hypogonadism patients.
He also uses the word "blast" without defining it. To a bodybuilding audience this is obvious slang for a high-dose testosterone cycle, often stacked with other compounds. But for a viewer who found this video through a TRT search, that term could be confusing or misleading. He does not clarify the risks of actual blasting, which are substantially greater than the risks of TRT alone, including cardiac remodeling documented by Baggish et al. (2017, Circulation: Heart Failure).
What should you actually know?
If your testosterone level comes back at 1800 ng/dL while on a prescribed TRT protocol, that is a red flag worth taking seriously, not panicking over, but acting on. Most regulated TRT programs aim to restore testosterone to a normal physiological range, not push it to the top of the chart or beyond it. What qualifies as normal varies by lab and age, but 1800 ng/dL exceeds the upper reference limit on essentially every standard assay.
The practical steps the creator mentions, getting bloodwork, adjusting dose, and splitting injections, are all sensible. But they should happen in consultation with a prescribing physician, not based on a TikTok reply. High testosterone can drive up hematocrit, raising clot risk. It can elevate blood pressure. It can suppress natural LH and FSH production. These are not theoretical concerns; they show up in clinical monitoring for exactly this reason.
- Do not adjust your TRT dose based on social media advice. That includes this video and this fact-check.
- If your levels are elevated, ask your prescriber to review your protocol before changing anything.
- Splitting injections is a legitimate clinical strategy, but the right frequency depends on the ester you are using and your individual lab response.
- E2 monitoring matters. Ask for an estradiol level alongside your testosterone panel.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Alpha Club Supplements UK · TikTok creator
3.6K views on this video
Replying to @alistairmurrayb Test level at 1800? Could be fine on a blast, but way too high for TRT. Check your dose, split your shots, and get bloodwork before it bites you.
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about 1800 ng/dl exceeds the upper reference limit on standard testosterone?
1800 ng/dL exceeds the upper reference limit on standard testosterone assays, which typically cap normal at 916 to 1050 ng/dL depending on the lab and method used.
What does the video say about the endocrine society (bhasin et al., 2018) recommends targeting mid-normal?
The Endocrine Society (Bhasin et al., 2018) recommends targeting mid-normal physiological testosterone ranges for hypogonadism, generally 400 to 700 ng/dL at trough, not 1100 ng/dL.
What does the video say about supraphysiologic testosterone drives aromatization to estradiol; ramasamy et al. (2014,?
Supraphysiologic testosterone drives aromatization to estradiol; Ramasamy et al. (2014, Urology) found that elevated E2 in men on TRT correlates with side effects including sexual dysfunction and fluid retention.
What does the video say about cardiovascular risk at sustained high testosterone levels?
Cardiovascular risk at sustained high testosterone levels is real: Baggish et al. (2017, Circulation: Heart Failure) documented left ventricular dysfunction and structural changes in long-term high-dose androgen users.
What does the video say about splitting testosterone injections to two?
Splitting testosterone injections to two or three times per week is a clinically recognized strategy for reducing peak serum concentrations and smoothing hormone levels, per AUA 2018 testosterone therapy guidelines.
What does the video say about any dose adjustment for elevated testosterone should be made with?
Any dose adjustment for elevated testosterone should be made with a prescribing physician who can review full labs including hematocrit, estradiol, and blood pressure, not based on social media advice.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Alpha Club Supplements UK, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.